Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06405945

Cervical Cancer Susceptible Population Classification

Evalutaion of the SNPs Test in Average Cervical Cancer Screening Episode

Status
Recruiting
Phase
Study type
Observational
Enrollment
10,000 (estimated)
Sponsor
Anhui Provincial Hospital · Other Government
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

Cervical cancer is the third most common lethal tumor globally, causing around a quarter million deaths annually, despite the availability of HPV vaccines. Recent Genome-wide association studies (GWAS) have identified numerous genetic markers linked to cervical cancer, including rs10175462, rs10007915, rs35721900, and rs61646675, which have been verified as being related to susceptibility to cervical cancer. However, many reports lack clarity, consistency, and validation. In this comprehensive study, we will analyze the genomic risk factors associated with cervical cancer, classify individuals into different risk categories, and explore potential biomarkers and therapeutics.

Conditions

Interventions

TypeNameDescription
GENETICPCR and sequencesequence the mutatation SNPs

Timeline

Start date
2024-05-01
Primary completion
2034-04-30
Completion
2036-06-01
First posted
2024-05-09
Last updated
2024-05-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06405945. Inclusion in this directory is not an endorsement.